The Evaluation of Drug Utilization Review on Potentially Inappropriate Medications for Elderly Patients in a Tertiary Hospital
Korean Journal of Clinical Pharmacy
; : 25-32, 2019.
Article
en Ko
| WPRIM
| ID: wpr-759609
Biblioteca responsable:
WPRO
ABSTRACT
OBJECTIVE: South Korea made a list of potentially inappropriate medications (PIMs) for elderly patients in 2015 and has prompted medical professionals to prescribe proper medication by using the drug utilization review (DUR) system. It has been three years since the system was introduced, but related studies have rarely been conducted. This study aimed to evaluate the effect of the DUR system on the prescription of PIMs for elderly patients. METHODS: The data on the prescription of PIMs for elderly patients (≥ 65 years) who received medical treatment between March 1st and May 31st in 2015 (before introduction of the DUR system) and who received medical treatment between March 1st and May 31st in 2018 (after introduction of the DUR system) were retrospectively collected from electronic medical records. RESULTS: The prescriptions of PIMs decreased from 3,716 (7.7%) to 3,857 (6.9%) (p < 0.001). The prescription of escitalopram and paroxetine, among selective serotonin reuptake inhibitors, increased significantly, and that of short-acting benzodiazepines also increased significantly from 454 (0.93%) to 624 (1.2%). CONCLUSION: Prescription of PIMs for elderly patients significantly decreased (p < 0.001) after the DUR system was introduced. Further expanded studies of PIMs need to be conducted for the safety of elderly patients.
Palabras clave
Texto completo:
1
Índice:
WPRIM
Asunto principal:
Benzodiazepinas
/
Citalopram
/
Estudios Retrospectivos
/
Inhibidores Selectivos de la Recaptación de Serotonina
/
Paroxetina
/
Revisión de la Utilización de Medicamentos
/
Utilización de Medicamentos
/
Prescripciones
/
Registros Electrónicos de Salud
/
Centros de Atención Terciaria
Tipo de estudio:
Observational_studies
Límite:
Aged
/
Humans
País/Región como asunto:
Asia
Idioma:
Ko
Revista:
Korean Journal of Clinical Pharmacy
Año:
2019
Tipo del documento:
Article